Enavate Sciences GP, LLC

13F Portfolio Filings

  • Most recent 13F
    Q4 2024
  • Location
    menlo park, CA
  • CIK
    0001953107
  • All SEC filings
Q4 2024
Quater
Holdings
VALUE
Top Holdings
Form Type
Date Filed
Filing Id

5

$139.24M
UPSTREAM BIO INC, IMNM, ZENAS BIOPHARMA INC, CAMP4 THERAPEUTICS CORP
13F-HR
Feb 14, 2025
000110465925014094
Enavate Sciences Gp, Llc 13F Filings